This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Effects on Schizophrenic Symptoms

David S. Janowsky, MD; John M. Davis, MD

Arch Gen Psychiatry. 1976;33(3):304-308.

Abstract
• Methylphenidate hydrochloride dextroamphetamine sulfate, and levamfetamine succinate have potential as pharmacologic tools for the indirect evaluation of the role of neurotransmitters in schizophrenia. In actively ill schizophrenic patients, methylphenidate administered intravenously causes a brief but clear intensification of preexisting psychotic symptoms, such as hallucinations and delusions. In our study, methylphenidate, dextroamphetamine, and levamfetamine were administered in equimolar doses to schizophrenic patients. Methylphenidate was a more effective activator of symptoms than dextroamphetamine, which in turn was more effective than levamfetamine.

Levodopa (L-dopa) given orally also reportedly produces a temporary worsening of schizophrenic symptoms. While these findings augment a body of information suggesting that dopamine and norepinephrine may play a role in the activation of schizophrenic symptoms, our findings with methylphenidate (reportedly weak in eliciting sterotyped behaviour in rat) and our review of the literature indicate complexities that remain to be resolved. There is some utility of the procedure for differential diagnosis and selective therapy, but this is still of occasional and limited potential.

Author Affiliations
From the departments of psychiatry, University of California at San Diego Medical School (Dr Janowsky), and the University of Chicago School of Medicine and the Illinois State Psychiatric Institute, Chicago (Dr Davis).

Footnotes
Accepted for publication July 9, 1975.

Reprint requests to Department of Psychiatry, School of Medicine, University of California at San Diego, La Jolla, CA 92037 (Dr Janowsky).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dopamine Modulation of Emotional Processing in Cortical and Subcortical Neural Circuits: Evidence for a Final Common Pathway in Schizophrenia?
Laviolette
Schizophr Bull 2007;33:971-981.
ABSTRACT | FULL TEXT  

Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
Kapur
Am. J. Psychiatry 2003;160:13-23.
ABSTRACT | FULL TEXT  

Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies
Laruelle and Abi-Dargham
J Psychopharmacol 1999;13:358-371.
ABSTRACT  

Sources of Diagnostic Uncertainty for Chronically Psychotic Cocaine Abusers
Shaner et al.
Psychiatr. Serv. 1998;49:684-690.
ABSTRACT | FULL TEXT  

Importance of the Noradrenaline-Dopamine Coupling in the Locomotor Activating Effects of D-Amphetamine
Darracq et al.
J. Neurosci. 1998;18:2729-2739.
ABSTRACT | FULL TEXT  

A Linkage Study of Chromosome 11q in Schizophrenia
Wang et al.
Arch Gen Psychiatry 1993;50:212-216.
ABSTRACT  

No Linkage Between D2 Dopamine Receptor Gene Region and Schizophrenia
Moises et al.
Arch Gen Psychiatry 1991;48:643-647.
ABSTRACT  

The Use of Psychostimulants in General Psychiatry: A Reconsideration
Chiarello and Cole
Arch Gen Psychiatry 1987;44:286-295.
ABSTRACT  

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics
Wong et al.
Science 1986;234:1558-1563.
ABSTRACT  

Antipsychotic Effects of Pimozide in Schizophrenia: Treatment Response Prediction With Acute Dextroamphetamine Response
van Kammen et al.
Arch Gen Psychiatry 1982;39:261-266.
ABSTRACT  

Long-term Pimozide Pretreatment Differentially Affects Behavioral Responses to Dextroamphetamine in Schizophrenia: Further Exploration of the Dopamine Hypothesis of Schizophrenia
van Kammen et al.
Arch Gen Psychiatry 1982;39:275-281.
ABSTRACT  

Lack of Behavioral Supersensitivity to d-Amphetamine After Pimozide Withdrawal: A Trial With Schizophrenic Patients
van Kammen et al.
Arch Gen Psychiatry 1980;37:287-290.
ABSTRACT  

Phenylethylamine in paranoid chronic schizophrenia
Potkin et al.
Science 1979;206:470-471.
ABSTRACT  

Clomipramine-Induced Mania in Unipolar Depression
van Scheyen and van Kammen
Arch Gen Psychiatry 1979;36:560-565.
ABSTRACT  

The Effect of Methylphenidate on Serum Growth Hormone: Influence of Antipsychotic Drugs and Diagnosis
Janowsky et al.
Arch Gen Psychiatry 1978;35:1384-1389.
ABSTRACT  

Psychologic and Neuroendocrine Response to Methylphenidate
Brown
Arch Gen Psychiatry 1977;34:1103-1108.
ABSTRACT  

Methylphenidate Hydrochloride Effects on Psychological Tests in Acute Schizophrenic and Nonpsychotic Patients
Janowsky et al.
Arch Gen Psychiatry 1977;34:189-194.
ABSTRACT